Drug Dissolution in Oral Drug Absorption: Workshop Report
Overview
Authors
Affiliations
The in-person workshop "Drug Dissolution in Oral Drug Absorption" was held on May 23-24, 2023, in Baltimore, MD, USA. The workshop was organized into lectures and breakout sessions. Three common topics that were re-visited by various lecturers were amorphous solid dispersions (ASDs), dissolution/permeation interplay, and in vitro methods to predict in vivo biopharmaceutics performance and risk. Topics that repeatedly surfaced across breakout sessions were the following: (1) meaning and assessment of "dissolved drug," particularly of poorly water soluble drug in colloidal environments (e.g., fed conditions, ASDs); (2) potential limitations of a test that employs sink conditions for a poorly water soluble drug; (3) non-compendial methods (e.g., two-stage or multi-stage method, dissolution/permeation methods); (4) non-compendial conditions (e.g., apex vessels, non-sink conditions); and (5) potential benefit of having both a quality control method for batch release and a biopredictive/biorelevant method for biowaiver or bridging scenarios. An identified obstacle to non-compendial methods is the uncertainty of global regulatory acceptance of such methods.
In Vitro-In Vivo Correlation Of Amorphous Solid Dispersion Enabled Itraconazole Tablets.
Coutinho A, Adhikari A, Krug S, Kane M, Hollenbeck R, Hoag S Pharm Res. 2025; .
PMID: 40069449 DOI: 10.1007/s11095-025-03837-z.
Tsume Y, Ashworth L, Bermejo Sanz M, Cicale V, Dressman J, Fushimi M Mol Pharm. 2024; 21(10):5315-5325.
PMID: 39311714 PMC: 11468891. DOI: 10.1021/acs.molpharmaceut.4c00878.